Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK

Letter presents study (n=14 929 251;Mar to Dec 2020) showing reductions in diagnosis & monitoring of type 2 diabetes during pandemic, warning health-care services will need to manage this predicted backlog, and anticipated deterioration of blood glucose levels & CV risk factors.

The Lancet Diabetes & Endocrinology